Navigation
Life Science Cluster für Hamburg und Schleswig-Holstein

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
Cellbox Ground 2.0 ushers in a new era of cell shipping: Live Cell Shipping.
Cellbox Ground 2.0 ushers in a new era of cell shipping: Live Cell Shipping. (Image: Cellbox Solutions)

Cellbox Solutions Awarded €2.5 Million Grant

Cellbox Solutions GmbH, a leading provider of warm chain logistics solutions for the research, development and shipment of cell-based therapies and cellular diagnostics, today announced ...

Read more …
Tiprelestat will be administered to patients hospitalized due to COVID-19 with the goal of reducing the duration of severe COVID-19.
Tiprelestat will be administered to patients hospitalized due to COVID-19 with the goal of reducing the duration of severe COVID-19. (Photo Credit: Alissa Eckert, MSMI; Dan Higgins, MAMS)

tiakis: Treatment of COVID-19

tiakis Biotech AG announced today that a first patient has been dosed in the COMCOVID trial, a Phase Ib/II trial evaluating the Company’s key investigational ...

Read more …
From left to right: a pollen grain collected at DESY, a diatom, and a cyanobacterium, all imaged using Compton X-ray Scattering Microscopy at PETRA III.
From left to right: a pollen grain collected at DESY, a diatom, and a cyanobacterium, all imaged using Compton X-ray Scattering Microscopy at PETRA III. (Image: ©DESY/CFEL)

Biological specimens imaged with X-rays without damage

A pollen grain showing the nanofoam within or a diatom with the individual geometric structures inside clearly visible: Using high-energy X-rays from the PETRA III ...

Read more …
Hamburg's Senator for Economics and Innovation, Dr. Melanie Leonhard, met Dr. Werner Lanthaler, Evotec CEO (left), and Dirk Winkler, SVP Hit Identification, Global Drug Discovery Services at Evotec (right), during her visit to the Manfred Eigen campus.
Hamburg's Senator for Economics and Innovation, Dr. Melanie Leonhard, met Dr. Werner Lanthaler, Evotec CEO (left), and Dirk Winkler, SVP Hit Identification, Global Drug Discovery Services at Evotec (right), during her visit to the Manfred Eigen campus. ( Picture: © Nico Michaelsen, Evotec SE)

Senator Dr. Melanie Leonhard visits Evotec

Evotec SE announced that new high-throughput screening (“HTS”) facilities at the Company’s headquarters in Hamburg, as well as additional equipment for investigating ...

Read more …
tiakis focuses on the discovery and development of therapeutic solutions based on its innovative biopharmaceutical Tiprelestat for life threatening surgeries and life-threatening diseases such as PAH and COVID-19.
tiakis focuses on the discovery and development of therapeutic solutions based on its innovative biopharmaceutical Tiprelestat for life threatening surgeries and life-threatening diseases such as PAH and COVID-19. (Image: ©stock.adobe.com/Gorodenkoff)

tiakis Biotech AG and Northway Biotech collaborate

tiakis Biotech AG (tiakis), in collaboration with its CDMO partner Northway Biotech, is pleased to announce the successful ...

Read more …
Frank Horling, PhD, Managing Director of BioAgilytix in Hamburg, cuts the ribbon. (Image: © BioAgilytix Europe GmbH)
Frank Horling, PhD, Managing Director of BioAgilytix in Hamburg, cuts the ribbon. (Image: © BioAgilytix Europe GmbH)

BioAgilytix Expands Hamburg Lab

BioAgilytix, a leading global bioanalytical lab, announced the expansion and GMP certification of its facility in Hamburg, Germany. The enhanced footprint and addition ...

Read more …
For academic research, MHH will receive access to the data generated within the partnership by working with Evotec’s AI-driven analytics software PanHunter. (Picture: © Evotec)

Evotec enters partnership with Hannover Medical School

Evotec SE announced that the Company has entered a partnership with Hannover Medical School (“MHH”), one of the leading German universities, to ...

Read more …
New construction receives platinum sustainability certificate from the German Sustainable Building Council. (Source: © Eppendorf SE)

Eppendorf expands high-tech site in Jülich

The globally positioned Eppendorf Group is expanding its bioprocess site in Jülich, Germany with the construction of a new state-of-the-art multifunctional building. The ...

Read more …
Preview of the new biologics manufacturing plant J.POD® Toulouse, France (EU); (Image: © Brunerie & Irissou Architectes, Thomas Brunerie)

Evotec initiates ground-breaking for new biologics facility

Evotec SE today officially launched the construction of its J.POD® biologics manufacturing facility at Evotec’s Campus Curie in Toulouse, France. J.POD® Toulouse, ...

Read more …
Dr. Christian Regenbrecht, CEO of CELLphenomics (2nd from left) and Prof. Dr. Hartmut Juhl, CEO and founder of Indivumed (2nd from right) are pleased about the agreed partnership. ( Picture: © Indivumed)

Indivumed and CELLphenomics Announce Partnership

Indivumed GmbH (“Indivumed”) and CELLphenomics GmbH (“CELLphenomics”) today announced a partnership to create a unique platform for faster and more efficient discovery and validation of ...

Read more …
Repurposing drugs as the new normal (Photo: © Fraunhofer ITMP | Perspektive Media)

REMEDi4ALL project launched

REMEDi4ALL is expected to make a major leap forward in drug repurposing, or finding new therapeutic option for ...

Read more …
The paper's main author Vasundara Srinivasan at an X-ray set-up to test protein crystals in the lab. Credit: University of Hamburg, Susanna Gevorgyan (Credit: © University of Hamburg, Susanna Gevorgyan)

Natural substances show promise against coronavirus

Three natural compounds present in foods like green tea, olive oil and red wine are promising candidates for the development of drugs against the coronavirus. ...

Read more …
Job board